In this context, COVID-19 patients displaying alterations in the T cell compartment that leans toward the functional phenotype Th17 could favor the occurrence of hyperinflammation by the exacerbated release of IL-17, a potent chemoattract/activator for human neutrophils (51). Here, IL17A is linked to COVID-19.